ID   BRE1B_HUMAN             Reviewed;        1001 AA.
AC   O75150; Q6AHZ6; Q6N005; Q7L3T6; Q8N615; Q96T18; Q9BSV9; Q9HC82;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 4.
DT   10-MAY-2017, entry version 147.
DE   RecName: Full=E3 ubiquitin-protein ligase BRE1B;
DE            Short=BRE1-B;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:16307923, ECO:0000269|PubMed:19410543};
DE   AltName: Full=95 kDa retinoblastoma-associated protein;
DE            Short=RBP95;
DE   AltName: Full=RING finger protein 40;
DE   AltName: Full=RING-type E3 ubiquitin transferase BRE1B {ECO:0000305};
GN   Name=RNF40; Synonyms=BRE1B, KIAA0661;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, SUBUNIT, INTERACTION WITH RB1, MUTAGENESIS OF LEU-109;
RP   CYS-111 AND GLU-113, AND VARIANT ARG-615.
RC   TISSUE=Fetal brain;
RX   PubMed=10944455; DOI=10.1006/bbrc.2000.3242;
RA   Wen H., Ao S.;
RT   "RBP95, a novel leucine zipper protein, binds to the retinoblastoma
RT   protein.";
RL   Biochem. Biophys. Res. Commun. 275:141-148(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-615.
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND VARIANT
RP   ARG-615.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-615.
RC   TISSUE=Cervix, and Rectum tumor;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-615.
RC   TISSUE=Brain, Mammary gland, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, AND IDENTIFICATION IN A COMPLEX
RP   WITH RNF20 AND UBE2E1.
RX   PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025;
RA   Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H.,
RA   Tempst P., Reinberg D.;
RT   "Monoubiquitination of human histone H2B: the factors involved and
RT   their roles in HOX gene regulation.";
RL   Mol. Cell 20:601-611(2005).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBUNIT.
RX   PubMed=19410543; DOI=10.1016/j.cell.2009.02.027;
RA   Kim J., Guermah M., McGinty R.K., Lee J.S., Tang Z., Milne T.A.,
RA   Shilatifard A., Muir T.W., Roeder R.G.;
RT   "RAD6-mediated transcription-coupled H2B ubiquitylation directly
RT   stimulates H3K4 methylation in human cells.";
RL   Cell 137:459-471(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   INTERACTION WITH WAC.
RX   PubMed=21329877; DOI=10.1016/j.molcel.2011.01.024;
RA   Zhang F., Yu X.;
RT   "WAC, a functional partner of RNF20/40, regulates histone H2B
RT   ubiquitination and gene transcription.";
RL   Mol. Cell 41:384-397(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Component of the RNF20/40 E3 ubiquitin-protein ligase
CC       complex that mediates monoubiquitination of 'Lys-120' of histone
CC       H2B (H2BK120ub1). H2BK120ub1 gives a specific tag for epigenetic
CC       transcriptional activation and is also prerequisite for histone H3
CC       'Lys-4' and 'Lys-79' methylation (H3K4me and H3K79me,
CC       respectively). It thereby plays a central role in histone code and
CC       gene regulation. The RNF20/40 complex forms a H2B ubiquitin ligase
CC       complex in cooperation with the E2 enzyme UBE2A or UBE2B; reports
CC       about the cooperation with UBE2E1/UBCH are contradictory. Required
CC       for transcriptional activation of Hox genes.
CC       {ECO:0000269|PubMed:16307923, ECO:0000269|PubMed:19410543}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:16307923,
CC       ECO:0000269|PubMed:19410543}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Component of the RNF20/40 complex (also known as BRE1
CC       complex) probably composed of 2 copies of RNF20/BRE1A and 2 copies
CC       of RNF40/BRE1B. Interacts with UBE2E1/UBCH6. Interacts with RB1
CC       and WAC. {ECO:0000269|PubMed:10944455,
CC       ECO:0000269|PubMed:16307923, ECO:0000269|PubMed:19410543,
CC       ECO:0000269|PubMed:21329877}.
CC   -!- INTERACTION:
CC       Q9Y2J4-4:AMOTL2; NbExp=3; IntAct=EBI-744408, EBI-10187270;
CC       Q8IYE0-2:CCDC146; NbExp=3; IntAct=EBI-744408, EBI-10247802;
CC       P42858:HTT; NbExp=3; IntAct=EBI-744408, EBI-466029;
CC       Q09161:NCBP1; NbExp=3; IntAct=EBI-744408, EBI-464743;
CC       P06400:RB1; NbExp=3; IntAct=EBI-744408, EBI-491274;
CC       Q5VTR2:RNF20; NbExp=10; IntAct=EBI-744408, EBI-2372238;
CC       Q86XK3:SFR1; NbExp=3; IntAct=EBI-744408, EBI-1104535;
CC       Q7KZS0:UBE2I; NbExp=3; IntAct=EBI-744408, EBI-10180829;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10944455}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O75150-1; Sequence=Displayed;
CC       Name=3;
CC         IsoId=O75150-3; Sequence=VSP_016682, VSP_016683;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=O75150-4; Sequence=VSP_016681;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expressed at higher
CC       level in testis, heart and pancreas, while it is only weakly
CC       expressed in lung, skeletal muscle and small intestine.
CC       {ECO:0000269|PubMed:10944455}.
CC   -!- SIMILARITY: Belongs to the BRE1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA31636.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAE45869.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF122819; AAG13723.1; -; mRNA.
DR   EMBL; AB014561; BAA31636.2; ALT_INIT; mRNA.
DR   EMBL; AK027406; BAB55092.1; -; mRNA.
DR   EMBL; BX640763; CAE45869.1; ALT_SEQ; mRNA.
DR   EMBL; CR627431; CAH10518.1; -; mRNA.
DR   EMBL; AC106886; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004527; AAH04527.2; -; mRNA.
DR   EMBL; BC006133; AAH06133.1; -; mRNA.
DR   EMBL; BC011769; AAH11769.1; -; mRNA.
DR   EMBL; BC018647; AAH18647.1; -; mRNA.
DR   EMBL; BC030802; AAH30802.2; -; mRNA.
DR   CCDS; CCDS10691.1; -. [O75150-1]
DR   CCDS; CCDS55994.1; -. [O75150-4]
DR   PIR; JC7363; JC7363.
DR   RefSeq; NP_001193962.1; NM_001207033.1.
DR   RefSeq; NP_001193963.1; NM_001207034.1.
DR   RefSeq; NP_001273501.1; NM_001286572.2.
DR   RefSeq; NP_055586.1; NM_014771.3.
DR   UniGene; Hs.65238; -.
DR   ProteinModelPortal; O75150; -.
DR   SMR; O75150; -.
DR   BioGrid; 115149; 82.
DR   IntAct; O75150; 32.
DR   MINT; MINT-1466706; -.
DR   STRING; 9606.ENSP00000325677; -.
DR   iPTMnet; O75150; -.
DR   PhosphoSitePlus; O75150; -.
DR   BioMuta; RNF40; -.
DR   EPD; O75150; -.
DR   MaxQB; O75150; -.
DR   PaxDb; O75150; -.
DR   PeptideAtlas; O75150; -.
DR   PRIDE; O75150; -.
DR   DNASU; 9810; -.
DR   Ensembl; ENST00000324685; ENSP00000325677; ENSG00000103549.
DR   Ensembl; ENST00000357890; ENSP00000350563; ENSG00000103549.
DR   GeneID; 9810; -.
DR   KEGG; hsa:9810; -.
DR   UCSC; uc002dzq.4; human. [O75150-1]
DR   CTD; 9810; -.
DR   DisGeNET; 9810; -.
DR   GeneCards; RNF40; -.
DR   HGNC; HGNC:16867; RNF40.
DR   HPA; HPA041330; -.
DR   HPA; HPA054227; -.
DR   MIM; 607700; gene.
DR   neXtProt; NX_O75150; -.
DR   PharmGKB; PA34440; -.
DR   eggNOG; KOG0978; Eukaryota.
DR   eggNOG; ENOG410Y5C6; LUCA.
DR   HOVERGEN; HBG080312; -.
DR   InParanoid; O75150; -.
DR   KO; K10696; -.
DR   OrthoDB; EOG091G01SA; -.
DR   PhylomeDB; O75150; -.
DR   TreeFam; TF323183; -.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   SIGNOR; O75150; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RNF40; human.
DR   GeneWiki; RNF40; -.
DR   GenomeRNAi; 9810; -.
DR   PRO; PR:O75150; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000103549; -.
DR   CleanEx; HS_RNF40; -.
DR   ExpressionAtlas; O75150; baseline and differential.
DR   Genevisible; O75150; HS.
DR   GO; GO:0043679; C:axon terminus; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0019898; C:extrinsic component of membrane; IEA:Ensembl.
DR   GO; GO:0033503; C:HULC complex; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0017075; F:syntaxin-1 binding; IEA:Ensembl.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IEA:Ensembl.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0033523; P:histone H2B ubiquitination; IDA:UniProtKB.
DR   GO; GO:0010390; P:histone monoubiquitination; IDA:UniProtKB.
DR   GO; GO:1900364; P:negative regulation of mRNA polyadenylation; IMP:UniProtKB.
DR   GO; GO:2001168; P:positive regulation of histone H2B ubiquitination; IMP:UniProtKB.
DR   GO; GO:1901800; P:positive regulation of proteasomal protein catabolic process; IEA:Ensembl.
DR   GO; GO:1902916; P:positive regulation of protein polyubiquitination; IEA:Ensembl.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chromatin regulator; Coiled coil;
KW   Complete proteome; Metal-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1   1001       E3 ubiquitin-protein ligase BRE1B.
FT                                /FTId=PRO_0000055839.
FT   ZN_FING     948    987       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   COILED       44     91       {ECO:0000255}.
FT   COILED      189    377       {ECO:0000255}.
FT   COILED      437    525       {ECO:0000255}.
FT   COILED      627    946       {ECO:0000255}.
FT   MOD_RES      20     20       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q3U319}.
FT   MOD_RES      42     42       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5VTR2}.
FT   MOD_RES     355    355       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q5VTR2}.
FT   MOD_RES     517    517       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q3U319}.
FT   MOD_RES     528    528       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5VTR2}.
FT   MOD_RES     585    585       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3U319}.
FT   VAR_SEQ     332    431       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_016681.
FT   VAR_SEQ     822    838       DAQLLTVQKLEEKERAL -> WPPPACRLELERWGSWP
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:10944455}.
FT                                /FTId=VSP_016682.
FT   VAR_SEQ     839   1001       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10944455}.
FT                                /FTId=VSP_016683.
FT   VARIANT     463    463       R -> H (in dbSNP:rs11556801).
FT                                /FTId=VAR_055021.
FT   VARIANT     615    615       Q -> R (in dbSNP:rs7195142).
FT                                {ECO:0000269|PubMed:10944455,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|PubMed:9734811}.
FT                                /FTId=VAR_055022.
FT   MUTAGEN     109    109       L->S: Abolishes interaction with RB1.
FT                                {ECO:0000269|PubMed:10944455}.
FT   MUTAGEN     111    111       C->M: Abolishes interaction with RB1.
FT                                {ECO:0000269|PubMed:10944455}.
FT   MUTAGEN     113    113       E->Q: Abolishes interaction with RB1.
FT                                {ECO:0000269|PubMed:10944455}.
FT   CONFLICT     56     56       N -> D (in Ref. 3; BAB55092).
FT                                {ECO:0000305}.
FT   CONFLICT     96     96       R -> L (in Ref. 1; AAG13723).
FT                                {ECO:0000305}.
FT   CONFLICT    108    108       L -> P (in Ref. 3; BAB55092).
FT                                {ECO:0000305}.
FT   CONFLICT    172    172       S -> G (in Ref. 3; BAB55092).
FT                                {ECO:0000305}.
FT   CONFLICT    387    387       E -> K (in Ref. 4; CAH10518).
FT                                {ECO:0000305}.
FT   CONFLICT    562    562       K -> E (in Ref. 4; CAE45869).
FT                                {ECO:0000305}.
FT   CONFLICT    600    600       S -> F (in Ref. 4; CAE45869).
FT                                {ECO:0000305}.
FT   CONFLICT    714    714       D -> N (in Ref. 3; BAB55092).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1001 AA;  113650 MW;  82D7CD183EDD5EFC CRC64;
     MSGPGNKRAA GDGGSGPPEK KLSREEKTTT TLIEPIRLGG ISSTEEMDLK VLQFKNKKLA
     ERLEQRQACE DELRERIEKL EKRQATDDAT LLIVNRYWAQ LDETVEALLR CHESQGELSS
     APEAPGTQEG PTCDGTPLPE PGTSELRDPL LMQLRPPLSE PALAFVVALG ASSSEEVELE
     LQGRMEFSKA AVSRVVEASD RLQRRVEELC QRVYSRGDSE PLSEAAQAHT RELGRENRRL
     QDLATQLQEK HHRISLEYSE LQDKVTSAET KVLEMETTVE DLQWDIEKLR KREQKLNKHL
     AEALEQLNSG YYVSGSSSGF QGGQITLSMQ KFEMLNAELE ENQELANSRM AELEKLQAEL
     QGAVRTNERL KVALRSLPEE VVRETGEYRM LQAQFSLLYN ESLQVKTQLD EARGLLLATK
     NSHLRHIEHM ESDELGLQKK LRTEVIQLED TLAQVRKEYE MLRIEFEQNL AANEQAGPIN
     REMRHLISSL QNHNHQLKGD AQRYKRKLRE VQAEIGKLRA QASGSAHSTP NLGHPEDSGV
     SAPAPGKEEG GPGPVSTPDN RKEMAPVPGT TTTTTSVKKE ELVPSEEDFQ GITPGAQGPS
     SRGREPEARP KRELQEREGP SLGPPPVASA LSRADREKAK VEETKRKESE LLKGLRAELK
     KAQESQKEMK LLLDMYKSAP KEQRDKVQLM AAERKAKAEV DELRSRIREL EERDRRESKK
     IADEDALRRI RQAEEQIEHL QRKLGATKQE EEALLSEMDV TGQAFEDMQE QNGRLLQQLR
     EKDDANFKLM SERIKANQIH KLLREEKDEL GEQVLGLKSQ VDAQLLTVQK LEEKERALQG
     SLGGVEKELT LRSQALELNK RKAVEAAQLA EDLKVQLEHV QTRLREIQPC LAESRAAREK
     ESFNLKRAQE DISRLRRKLE KQRKVEVYAD ADEILQEEIK EYKARLTCPC CNTRKKDAVL
     TKCFHVFCFE CVRGRYEARQ RKCPKCNAAF GAHDFHRIYI S
//
